Many survivors from severe coronavirus disease 2019 (COVID‐19) suffer from persistent
dyspnea and fatigue long after resolution of the active infection. In a cohort of 21 consecutive …

Rationale: Dyspnea is often a persistent symptom after acute coronavirus disease (COVID-
19), even if cardiac and pulmonary function are normal. Objectives: This study investigated …

Purpose Symptoms often persistent for more than 4 weeks after COVID-19—now commonly
referred to as 'Long COVID'. Independent of initial disease severity or pathological …

Objectives Severe forms of the novel coronavirus-19 (COVID-19) are associated with
systemic inflammation and hypercatabolism. The aims of this study were to compare the time …

Background: Intensive care patients commonly develop muscle wasting and functional
impairment. However, the role of severe COVID-19 in the magnitude of muscle wasting and …

Some COVID-19 patients experience dyspnea without objective impairment of pulmonary or
cardiac function. This study determined diaphragm function and its central voluntary …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in
multiorgan damage primarily mediated by viral infiltration via angiotensin-converting …

Purpose To evaluate if reduced muscle mass, assessed with Computed Tomography (CT),
is a predictor of intensive care unit (ICU) hospitalization in COVID-19 patients. Methods In …

Both laboratory investigations and body composition quantification measures (eg, computed
tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) …

Background Intensive care unit acquired weakness (ICU‐AW) affects both coronavirus
disease 19 (COVID‐19) and non‐COVID‐19 patients. ICU‐AW can result in a variety of …